BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7346837)

  • 1. Electromyographic changes induced by oral carnitine treatment in dialysis patients.
    Albertazzi A; Spisni C; Del Rosso G; Palmieri PF; Rossini PM
    Proc Clin Dial Transplant Forum; 1980; 10():1-6. PubMed ID: 7346837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electromyographic changes induced with oral supplements of carnitine in patients under regular periodical hemodialytic treatment].
    Albertazzi A; Spisni C; Del Rosso G; Gambi D; Rossini PM
    Minerva Nefrol; 1980; 27(4):647-9. PubMed ID: 7019772
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.
    Rocchi L; Feola I; Calvani M; D'Iddio S; Alfarone C; Frascarelli M
    Drugs Exp Clin Res; 1986; 12(8):707-11. PubMed ID: 3757765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
    Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
    Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment].
    Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF
    G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerated recovery of post-dialysis plasma carnitine fall by oral carnitine.
    Bizzi A; Mingardi G; Codegoni AM; Mecca G; Garattini S
    Biomedicine; 1978 Oct; 29(6):183-4. PubMed ID: 737275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
    Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
    Günal AI; Celiker H; Dönder E; Günal SY
    J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine in dialysed patients: the choice of dosage regimen.
    Berard E; Iordache A; Barrillon D; Bayle J
    Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine in hemodialysis patients.
    Butler B
    Nephrol Nurse; 1983; 5(5):32-3. PubMed ID: 6557366
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influencing uraemic patients, neuromuscular system by exercise during dialysis (author's transl)].
    Rehácek J; Rauser V
    Cas Lek Cesk; 1979; 118(39):1190-2. PubMed ID: 526990
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 15. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
    [No Abstract]   [Full Text] [Related]  

  • 16. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG
    J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].
    Kudoh Y; Shoji T; Oimatsu H; Kikuchi K; Imura O; Watarai I
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):195-202. PubMed ID: 6748336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy].
    Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A
    Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.